Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (391-400 of 420) with videos related to

Pageof 42
Sort By:
Journal of Clinical Microbiology|March 16, 2007
Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing EnterobacteriaceaeHelio S Sader, Mary J Ferraro, L Barth Reller, et al.
Open Forum Infectious Diseases|March 22, 2019
Antimicrobial Resistance Surveillance and New Drug DevelopmentHelio S Sader, Paul R Rhomberg, Andrew S Fuhrmeister, et al.
Jac-Antimicrobial Resistance|October 21, 2021
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016-19)Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 2025
Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023)Michael D Huband, Kelley A Fedler, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2018
ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countriesRodrigo E Mendes, Lalitagauri Deshpande, Jennifer M Streit, et al.
Journal of Clinical Microbiology|January 31, 2020
Correlation between Broth Microdilution and Disk Diffusion Results when Testing Ceftazidime-Avibactam against a Challenge Collection of <i>Enterobacterales</i> Isolates: Results from a Multilaboratory StudyHelio S Sader, Paul R Rhomberg, Sukantha Chandrasekaran, et al.
Memorias Do Instituto Oswaldo Cruz|December 13, 2006
Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?Soraya S Andrade, Helio S Sader, Ronald N Jones, et al.
International Journal of Antimicrobial Agents|May 24, 2016
In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013)Michael D Huband, Mariana Castanheira, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|March 14, 2013
Educational antimicrobial susceptibility testing as a critical component of microbiology laboratory proficiency programs: American Proficiency Institute results for 2007-2011Ronald N Jones, Teri Glick, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|December 15, 2015
Ceftaroline activity tested against viridans group streptococci from US hospitalsHelio S Sader, Paul R Rhomberg, Mariana Castanheira, et al.
Pageof 42

Showing results (391-400 of 420) with videos related to

Sort By:
Pageof 42
Journal of Clinical Microbiology|March 16, 2007
Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing EnterobacteriaceaeHelio S Sader, Mary J Ferraro, L Barth Reller, et al.
Open Forum Infectious Diseases|March 22, 2019
Antimicrobial Resistance Surveillance and New Drug DevelopmentHelio S Sader, Paul R Rhomberg, Andrew S Fuhrmeister, et al.
Jac-Antimicrobial Resistance|October 21, 2021
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016-19)Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 2025
Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023)Michael D Huband, Kelley A Fedler, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2018
ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countriesRodrigo E Mendes, Lalitagauri Deshpande, Jennifer M Streit, et al.
Journal of Clinical Microbiology|January 31, 2020
Correlation between Broth Microdilution and Disk Diffusion Results when Testing Ceftazidime-Avibactam against a Challenge Collection of <i>Enterobacterales</i> Isolates: Results from a Multilaboratory StudyHelio S Sader, Paul R Rhomberg, Sukantha Chandrasekaran, et al.
Memorias Do Instituto Oswaldo Cruz|December 13, 2006
Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?Soraya S Andrade, Helio S Sader, Ronald N Jones, et al.
International Journal of Antimicrobial Agents|May 24, 2016
In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013)Michael D Huband, Mariana Castanheira, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|March 14, 2013
Educational antimicrobial susceptibility testing as a critical component of microbiology laboratory proficiency programs: American Proficiency Institute results for 2007-2011Ronald N Jones, Teri Glick, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|December 15, 2015
Ceftaroline activity tested against viridans group streptococci from US hospitalsHelio S Sader, Paul R Rhomberg, Mariana Castanheira, et al.
Pageof 42